Table I.
NKT cells suppress cholestatic liver injury
Mouse strain | Pre-treatment | BDL | Plasma ALT activity (U/L) |
---|---|---|---|
Wild-type | Untreated | − | 30 ± 8 |
Untreated | sham | 42 ± 11 | |
Untreated | + | 305 ± 90a | |
Jα18−/− | Untreated | + | 704 ± 94 |
Adoptive transfer | + | 391 ± 100b |
NOTE: Groups of mice were untreated or inoculated i.v. with 5 ×105 purified NKT cells (adoptive transfer) at 18 hours prior to surgery. Plasma was collected on day 3 following BDL or sham operations, and ALT levels were quantified. Data are derived from two or more experiments and plasma samples obtained from ≥6 mice.
Significantly greater than non-operated or sham-operated control animals; P<0.001.
Significantly less than Jα18−/ − mice not administered NKT cells: P=0.049.